NICHOLAS INVESTMENT PARTNERS, LP Intra-Cellular Therapies, Inc. Transaction History

NICHOLAS INVESTMENT PARTNERS, LP portfolio value:

$18.17M
portfolio value

NICHOLAS INVESTMENT PARTNERS, LP quarter portfolio value change:

-18.48%
quarter

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -9.97% -43.28K shares -6.59M $46.53 390.67K
Q2 2022 share Decrease -22.83% -128.41K shares -9.64M $57.08 433.95K
Q1 2022 share Decrease -13.86% -90.51K shares 240K $61.19 562.37K
Q4 2021 share Increase +6.47% 39.67K shares 11.31M $52.13 652.88K
Q3 2021 share Increase +2.50% 14.95K shares -1.56M $37.28 613.21K
Q2 2021 share Increase +7.88% 43.71K shares 5.60M $40.82 598.26K
Q1 2021 share Increase +42.09% 164.25K shares 6.40M $33.93 554.54K
Q4 2020 share Decrease -14.73% -67.43K shares 666K $31.8 390.28K
Q3 2020 share Increase 0.00% 457.72K shares 11.74M $25.66 457.72K
Q4 2016 share Decrease -100.00% -43.18K shares -658K $15.09 0
Q3 2016 share Decrease -6.94% -3.21K shares -1.14M $15.24 43.18K
Q2 2016 share Increase 0.00% 46.4K shares 1.80M $38.82 46.4K